Form 144/A - Report of proposed sale of securities: [Amend]
SEC Accession No. 0001958244-24-002818
Filing Date
2024-06-25
Accepted
2024-06-25 16:44:23
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144/A  
1 primary_doc.xml 144/A 4102
  Complete submission text file 0001958244-24-002818.txt   5782
Mailing Address 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET #455 EMERYVILLE CA 94608 5105052680
4D Molecular Therapeutics, Inc. (Subject) CIK: 0001650648 (see all company filings)

EIN.: 473506994 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144/A | Act: 33 | File No.: 001-39782 | Film No.: 241069499
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O 4D MOLECULAR THERAPEUTICS INC. 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address
Kirn David (Reporting) CIK: 0001834021 (see all company filings)

Type: 144/A